U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148154) titled 'Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations' on Aug. 21.
Brief Summary: CYTOMARK, a non-invasive in vitro diagnostic (IVD) test measuring a defined panel of protein biomarkers in cervical fluid, can accurately detect endometrial cancer in both symptomatic and asymptomatic women at high risk for the disease. The aim of the study consists in validating CYTOMARK's ELISA test, creating and freezing an algorithm detect EC in post-menopausal women with abnormal uterine bleeding (AUB).
Study Start Date: June 24, 2024
Study Type: OBSERVATIONAL
Condition:
Endometrial Cancer
Intervention: ...